Specific T-cell receptor gene transfer enhances immune response: A potential therapeutic strategy for the control of human cytomegalovirus infection in immunocompromised patients-Reference-Cited by-同舟云学术

Specific T-cell receptor gene transfer enhances immune response: A potential therapeutic strategy for the control of human cytomegalovirus infection in immunocompromised patients

Published:2019-02 Issue: Volume:336 Page:58-65
ISSN:0008-8749
Container-title:Cellular Immunology
language:en
Short-container-title:Cellular Immunology

Author:

Zhang Runan,Zhang Yanyue,Hu Jianhua,Wu Wei,Chen Xiaoming,Lu Zhongjie,Yang Rong,Huang Yaping,Fan Jun

Funder

Zhejiang Provincial Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Immunology

Reference32 articles.

1. Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation;Lin;J. Hematol. Oncol.,2013

2. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells;Ozdemir;Blood,2002

3. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials;Hodson;Lancet,2005

4. Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients;Kalil;Ann. Intern. Med.,2005

5. New developments in the management of cytomegalovirus infection after transplantation;Meesing;Drugs,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secretion of IFN-γ by specific T cells in HCMV infection;Heliyon;2024-03

2. Early immune surveillance to predict cytomegalovirus outcomes after allogeneic hematopoietic stem cell transplantation;Frontiers in Cellular and Infection Microbiology;2022-08-03

3. Flavonoids Target Human Herpesviruses That Infect the Nervous System: Mechanisms of Action and Therapeutic Insights;Viruses;2022-03-13

4. ELISPOT assay of interferon‐γ secretion for evaluating human cytomegalovirus reactivation risk in allo‐HSCT recipients;Journal of Medical Virology;2021-06-09